Strategic portfolio management, new technology/platform developments and opportunities, in-licensing opportunities, due diligence, business plans, IP landscape analysis and strategy, disease and target scouting, drug discovery and development, translational medicine & biomarkersStrategic scientific management, project plans, definition of key milestones and deliverables, inspire and challenge project teams, scout, establish and manage high-quality partnerships and outsourcing opportunities.Experience and broad knowledge in Nanobodies (and other single domain formats), mouse and human monoclonal antibodies, antibody fragments or derivatives (scFv, Fab, Fc, ...), protein scaffolds, peptides, SME’s;Blood brain barrier crossing technologies, selective tissue/cellular targeting, half life extension technologies, intracellular delivery, vaccine development;Viral, bacterial and fungal infections, inflammatory diseases, respiratory diseases, cancer (cell proliferation and apoptosis, angiogenesis, metastasis), CNS, metabolic diseases (diabetes, obesity, bone);Special expertise in: biologicals against GPCRs and Ion channels